161 related articles for article (PubMed ID: 32598310)
1. Androgen-driven COVID-19 infection - is testosterone an enemy or a friend?
Grubić Kezele T
Horm Mol Biol Clin Investig; 2020 Jun; 41(2):. PubMed ID: 32598310
[No Abstract] [Full Text] [Related]
2. Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes.
Dhurandhar NV; Akheruzzaman M; Hegde V
Nutr Diabetes; 2020 Aug; 10(1):30. PubMed ID: 32788586
[No Abstract] [Full Text] [Related]
3. COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.
Dhawan R; Gundry RL; Brett-Major DM; Mahr C; Thiele GM; Lindsey ML; Anderson DR
J Mol Cell Cardiol; 2020 Jul; 144():12-14. PubMed ID: 32339565
[No Abstract] [Full Text] [Related]
4. Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic.
Pozzilli P; Lenzi A
Metabolism; 2020 Jul; 108():154252. PubMed ID: 32353355
[No Abstract] [Full Text] [Related]
5. COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.
Mjaess G; Karam A; Aoun F; Albisinni S; Roumeguère T
Prog Urol; 2020 Sep; 30(10):484-487. PubMed ID: 32620366
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and androgen-targeted therapy for prostate cancer patients.
Bhowmick NA; Oft J; Dorff T; Pal S; Agarwal N; Figlin RA; Posadas EM; Freedland SJ; Gong J
Endocr Relat Cancer; 2020 Sep; 27(9):R281-R292. PubMed ID: 32508311
[TBL] [Abstract][Full Text] [Related]
7. ACE2 receptor expression in testes: implications in coronavirus disease 2019 pathogenesis†.
Verma S; Saksena S; Sadri-Ardekani H
Biol Reprod; 2020 Aug; 103(3):449-451. PubMed ID: 32427288
[TBL] [Abstract][Full Text] [Related]
8. Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor
Nowak JK; Lindstrøm JC; Kalla R; Ricanek P; Halfvarson J; Satsangi J
Gastroenterology; 2020 Sep; 159(3):1151-1154.e2. PubMed ID: 32413354
[No Abstract] [Full Text] [Related]
9. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19.
Steardo L; Steardo L; Zorec R; Verkhratsky A
Acta Physiol (Oxf); 2020 Jul; 229(3):e13473. PubMed ID: 32223077
[No Abstract] [Full Text] [Related]
10. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.
Wysocki J; Lores E; Ye M; Soler MJ; Batlle D
J Am Soc Nephrol; 2020 Sep; 31(9):1941-1943. PubMed ID: 32669323
[No Abstract] [Full Text] [Related]
11. Exercise as medicine for COVID-19: An ACE in the hole?
Heffernan KS; Jae SY
Med Hypotheses; 2020 Sep; 142():109835. PubMed ID: 32428811
[No Abstract] [Full Text] [Related]
12. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
Drak Alsibai K
Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: gastrointestinal symptoms and potential sources of SARS-CoV-2 transmission.
Kotfis K; Skonieczna-Żydecka K
Anaesthesiol Intensive Ther; 2020; 52(2):171-172. PubMed ID: 32200613
[No Abstract] [Full Text] [Related]
14. Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
Deng JL; Jiang YQ; Guo YK; Li HL
Chin Med J (Engl); 2020 Nov; 133(22):2650-2652. PubMed ID: 32804730
[No Abstract] [Full Text] [Related]
15. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection.
Kong Q; Xiang Z; Wu Y; Gu Y; Guo J; Geng F
Mol Cancer; 2020 Apr; 19(1):80. PubMed ID: 32345328
[TBL] [Abstract][Full Text] [Related]
16. [Angiotensin-converting enzyme 2 and coronavirus: research update on pathogenesis of the infection induced by this indissoluble bond].
Hou P; Xu Q; Na J; Zhang BL; Wu H; Li P; Zhao XX
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):539-545. PubMed ID: 32159318
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.
Öztürk AB; Çağlayan B
Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945
[No Abstract] [Full Text] [Related]
18. [Angiotension converting enzyme 2 in the context of 2019 novel coronavirus infection：friend or foe？].
Yang JM; Meng X; Xue F; Zhang Y; Zhang C
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):527-531. PubMed ID: 32189489
[TBL] [Abstract][Full Text] [Related]
19. The ocular surface, coronaviruses and COVID-19.
Willcox MD; Walsh K; Nichols JJ; Morgan PB; Jones LW
Clin Exp Optom; 2020 Jul; 103(4):418-424. PubMed ID: 32406140
[TBL] [Abstract][Full Text] [Related]
20. [2019 novel coronavirus, angiotensin converting enzyme 2 and cardiovascular drugs].
Shi HZ; Ma P; Gao FY; Chen GL; Wang YH; Xian XD; Dong ED
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):532-538. PubMed ID: 32166940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
